Madrigal Pharmaceuticals, Inc. (Nasdaq: MGDL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.
Location: United States, Pennsylvania, Conshohocken
Employees: 51-200
Founded date: 2011
Investors 2
| Date | Name | Website |
| 23.03.2023 | Avoro Capi... | avorocapit... |
| - | Bay City C... | baycitycap... |
Mentions in press and media 12
| Date | Title | Description | Source |
| 06.03.2024 | Madrigal Pharmaceuticals Reports Inducement Grants under Nas... | - | globenewsw... |
| 10.11.2023 | Madrigal Pharmaceuticals Presents New Data from the Phase 3 ... | Data to be featured in an oral presentation at the American Association for the Study of Liver Disea... | einpresswi... |
| 28.04.2023 | Current NASH treatment hurdles highlighted, new drugs hailed... | Michael Betel, President and Founder of the Fatty Liver Alliance testifies at ICER. Fatty Liver Alli... | einpresswi... |
| 21.12.2022 | Madrigal Pharmaceuticals Announces $300+ Million in Financin... | - | globenewsw... |
| 19.12.2022 | A tiny biotech's experimental treatment for a silent disease... | Madrigal Pharmaceuticals is hoping to succeed where others have failed in treating NASH, a serious l... | businessin... |
| 19.12.2022 | Madrigal Pharmaceuticals Stock More Than Doubles on ‘NASH’ B... | After years of failed efforts to find a treatment for the liver condition known as NASH, biotechnolo... | barrons.co... |
| 08.06.2021 | MADRIGAL PHARMACEUTICALS, INC. Madrigal Pharmaceuticals Ann... | WEST CONSHOHOCKEN, Pa., June 08, 2021 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc (NASDAQ: MDG... | marketscre... |
| 12.10.2018 | Dermira Provides Launch Readiness Update for QBREXZA™ (glyco... | Full article from Dermira MENLO PARK, Calif., Sept. 5, 2018 – Dermira, Inc. (NASDAQ: DERM), a bioph... | baycitycap... |
| 31.05.2018 | Madrigal Achieves Liver Biopsy Endpoints in Patients with NA... | Full article from Madrigal Pharmaceuticals CONSHOHOCKEN, Pa., May 31, 2018 — Madrigal Pharmaceutica... | baycitycap... |
| 04.01.2018 | Madrigal: This Year’s Best Midcap Stock Was Virtually Unknow... | Article in Bloomberg Madrigal Pharmaceuticals Inc. — a player in the blockbuster contest to develop... | baycitycap... |
Show more